Use of a New Diagnostic Tool in the Detection and Characterization of Endometriosis Lesions
Recruiting
N/A
Interventional Study
Endometriosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 20 (estimated)
- Sponsor
- University Hospital, Toulouse · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Diagnostic wandering is one of the characteristics of endometriosis due to great anatomical and clinical variability but also due to poorly relevant diagnostic examinations. \[18F\]-FES PET/CT could on the one hand improve diagnosis by showing greater sensitivity than MRI and on the other hand make it possible to quantify and characterize the expression of ER from diagnosis and thus helping to gui…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Cases:
\- Painful patients with a VAS ≥ 4 treated surgically for painful symptoms related to endometriosis;
Controls:
* Patient with a VAS \< 4 treated surgically for endometriosis in the context of infertility;
* Age \> 18 years;
* Patient who provided informed consent;
* Pa…
Contacts